Xin Shu
department
Infectious Disease
Introduction

Xin Shu, MD

 

Title

Associate Professor of Department of infectious Disease

 

Research Interests

New methods to treat HBV and HCV

The diagnosis and treatment of liver cirrhosis

 

Education and Experience

 Residencies

·           2009, Associate Professor, The Third Affiliated Hospital of Sun Yat-sen University

·           1999, Attending Physician, The Third Affiliated Hospital of Sun Yat-sen University

·           1994, Fellow Doctor, The Third Affiliated Hospital of Sun Yat-sen University

Education

·           MD, the Sun Yat-sen University(2005)

·           Master, the Sun Yat-sen University (2000)

·           Bachlor, the Sun Yat-sen University (1994)

 

Publications

1: Zhang K, Pan X, Shu X, Cao H, Chen L, Zou Y, Deng H, Li G, Xu Q. Relationship between MIF-173 G/C polymorphism and susceptibility to chronic hepatitis B and HBV-induced liver cirrhosis. Cell Immunol. 2013 Apr;282(2):113-6. doi:10.1016/j.cellimm.2013.04.013. Epub 2013 May 6. PubMed PMID: 23770720.

2: Xu Q, Pan X, Shu X, Cao H, Li X, Zhang K, Lu J, Zou Y, Li X, Liu H, Zhang Y, Yang D, Ning Q, Shen G, Li G. Increased interleukin-32 expression in chronic hepatitis B virus-infected liver. J Infect. 2012 Oct;65(4):336-42. doi:10.1016/j.jinf.2012.05.009. Epub 2012 Jun 8. PubMed PMID: 22687868.

3: Pan X, Cao H, Lu J, Shu X, Xiong X, Hong X, Xu Q, Zhu H, Li G, Shen G. Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-κB. Mol Immunol. 2011 Jul;48(12-13):1573-7. doi:10.1016/j.molimm.2011.03.012. Epub 2011 Apr 8. PubMed PMID: 21481941.

4: Shu X, Xu QH, Chen N, Zhang K, Li G. [The clinic features and the short-term efficacy of entecavir treatment of the HBeAG negative acute-on-chronic hepatitis B liver failure]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008 Dec;22(6):481-3. Chinese. PubMed PMID: 19544652.

5: Zhang K, Shu X, Luo HF, Zhu FQ, Cao H, Xu QH, Li G. [ROG,GATA3 and T-bet mRNA levels in peripheral blood mononuclear cells in patients with chronic hepatitis B]. Nan Fang Yi Ke Da Xue Xue Bao. 2016 Feb;36(2):186-9. Chinese. PubMed PMID:26922013.

6: Chen LB, Shu X, Jie YS, Yang XA, Zhang K, Li G, Xu QH. [Short-term efficacy of adefovir dipivoxil as an add-on therapy in the pegylated IFNalpha-2a treatment for HBeAg positive chronic hepatitis B patients]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010 Feb;24(1):39-41. Chinese. PubMed PMID: 20848847.

7: Xu Z, Chen LB, Cao H, Shu X, Xu QH, Li G, Xie QF. [Efficacy of the 96-week adefovir dipivoxil therapy in patients with chronic hepatitis B]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010 Jun;24(3):224-6. Chinese. PubMed

 

Contact

Department of the Infectious Disease,

The 3rd Hospital of Sun Yat-sen University

600 Tianhe Road, Guangzhou, 510630

Phone:02085252081